spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  otitis media 

 HSMN NewsFeed - 28 May 2020
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
Devices Product Launch
 HSMN NewsFeed - 11 Dec 2019
FDA clears Cochlear's innovative new Osia(R) 2 hearing implant system
Devices FDA
 HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 22 Aug 2017
Preceptis Medical announces first patient enrollment in the Hummingbird(TM) TTS Office Study for Ear Tube Delivery and new journal publication
Devices
 HSMN NewsFeed - 10 Jul 2017
Novus Therapeutics Announces Change in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2016
ProclaRx Names Doug Martin as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2016
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 11 Dec 2015
Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2015
OticPharma Appoints Dr. Catherine C. Turkel as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2014
Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN(R) In Very Young Children Born Small For Gestational Age
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2014
Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2013
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Dec 2011
Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2011
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2010
Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Aug 2010
Otonomy Closes $38.5 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jul 2010
CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2010
Otonomy Closes $10 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Feb 2010
Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Feb 2010
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Dec 2009
Pfizer Provides U.S. Regulatory Update On Prevnar 13 Vaccine
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2009
PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
Devices Surgery Distribution
 HSMN NewsFeed - 13 Jan 2009
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2009
FDA Advisory Committee Unanimously Recommends Sabril(R) (vigabatrin) for the Treatment of Two Catastrophic Epilepsies
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Oct 2008
Arbor Pharmaceuticals Launches NEOTIC(tm) – A New Prescription Treatment for the Painful Symptoms of Common Middle Ear Infections
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2008
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
New Data Support Routine Childhood Vaccination With PREVENAR in Europe
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
Naglazyme Approved by Japanese Ministry of Health
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Feb 2008
Arbor Pharmaceuticals, Inc. Announces Agreement with Accentia Biopharmaceuticals, Inc. to Launch Company’s Second Pediatric Treatment
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2007
Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB(R) and COMVAX(R)
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 29 Nov 2007
New Medical Device and Irrigation Solution Exhibits Promising Results in the Removal of Bacterial Colonization in Chronic Sinus Infections
Devices
 HSMN NewsFeed - 2 Oct 2007
First-Of-Its-Kind Home-Use Monitor Detects Key Sign Of Middle Ear Infection In Children
Devices Monitoring
 HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Aug 2007
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jun 2007
New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 May 2007
MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2007
New Medical Device and Irrigation Solution Exhibits Promising Results in the Removal of Bacterial Colonization in Chronic Sinus and Ear Infections
Devices
 HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2007
European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2007
Merck Updates Prescribing Information for ROTATEQ(R), the Company's Vaccine to Help Prevent Rotavirus Gastroenteritis in Infants and Children
Biopharmaceuticals
 HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Dec 2006
Replidyne Completes Phase 2 Trial Enrollment
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Dec 2006
Alliant Pharmaceuticals Signs Co-Promotion Agreement With sanofi-aventis for Allegra(R) (fexofenadine hydrochloride) Oral Suspension
Biopharmaceuticals
 HSMN NewsFeed - 22 Nov 2006
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2006
Numax(R) Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis(R)
Biopharmaceuticals
 HSMN NewsFeed - 18 Oct 2006
FDA Approves Allegra(R) (fexofenadine hydrochloride) Oral Suspension for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Biopharmaceuticals
 HSMN NewsFeed - 13 Sep 2006
Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYS
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2006
Advancis Pharmaceutical Announces Positive Results for Amoxicillin PULSYS Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2006
Ranbaxy Receives Approval to Market Cefprozil Suspension
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jun 2006
Advancis Pharmaceutical Signs Contract Sales Agreement With Innovex
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2006
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2006
Advancis Pharmaceutical Strengthens Sales and Marketing Capability With Addition of Key Personnel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2006
American Pharmaceutical Partners Receives Two FDA Approvals for Ceftriaxone for Injection, USP, Maintaining Company's Leadership Position in the Cephalosporin Market
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Feb 2006
FDA Approves Merck's ROTATEQ(R), The Only Vaccine in the U.S. to Prevent Rotavirus Gastroenteritis, a Leading Cause of Severe Infant Diarrhea
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jan 2006
BioMarin Receives Marketing Approval for Naglazyme in European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jan 2006
Advancis Pharmaceutical Provides Update on Keflex Brand
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 41

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 41 additional stories matching:
otitis media
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.